2014 Annual Meeting | 3FC.003 - Clinical EEG
09:00 AM - 09:05 AM |
Introduction
Susan T. Herman, MD, FAAN |
|
09:05 AM - 09:45 AM |
Normal Adult EEG and Benign Variants
Selim R. Benbadis, MD, FAAN |
|
09:45 AM - 10:25 AM |
Recording Concepts and Artifacts
Susan T. Herman, MD, FAAN |
|
10:25 AM - 10:40 AM |
Break
|
|
10:40 AM - 11:20 AM |
Abnormal EEG: Focal and Generalized
John M. Stern, MD, FAAN |
|
11:20 AM - 12:00 PM |
Normal and Abnormal Neonatal and Pediatric EEG
Tammy Tsuchida, MD, PhD |
|
12:00 PM - 01:00 PM |
Lunch
|
|
01:00 PM - 01:40 PM |
Interictal and Ictal EEG in Adults
Michael R. Sperling, MD, FAAN |
|
01:40 PM - 02:20 PM |
Interictal and Ictal EEG in Infants and Children
Tobias Loddenkemper, MD, FAAN |
|
02:20 PM - 03:00 PM |
Ambulatory and Video-EEG monitoring: Indications, Utility, and Safety
Katherine H. Noe, MD, PhD, FAAN |
|
03:00 PM - 03:15 PM |
Break
|
|
03:15 PM - 03:55 PM |
Continuous EEG in the Critically Ill
Sarah E. Schmitt, MD |
|
03:55 PM - 05:00 PM |
EEG Unknowns
|
Susan T. Herman, MD, FAAN | The institution of Dr. Herman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioserenity. Dr. Herman has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for National Association of Epilepsy Centers. Dr. Herman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Treatment Options in Neurology. Dr. Herman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. The institution of Dr. Herman has received research support from Epilepsy Foundation; Epilepsy Learning Healthcare System. The institution of Dr. Herman has received research support from CREMedical. The institution of Dr. Herman has received research support from NIH/NINDS. The institution of Dr. Herman has received research support from Marinus. Dr. Herman has received personal compensation in the range of $500-$4,999 for serving as a Medical Director, Neurodiagnostics Program with Laboure College. Dr. Herman has a non-compensated relationship as a Professional Advisory Board member with Epilepsy Foundation that is relevant to AAN interests or activities. |
Selim R. Benbadis, MD, FAAN | Dr. Benbadis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stratus. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Lifesciences. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. Dr. Benbadis has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurelis. Dr. Benbadis has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Benbadis has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Livanova. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Benbadis has received research support from Greenwich/Jazz. The institution of Dr. Benbadis has received research support from SK Lifesciences. |
Tobias Loddenkemper, MD, FAAN | No disclosure on file |
Michael R. Sperling, MD, FAAN | Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for International Medical Press. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Projects for Knowledge. The institution of Dr. Sperling has received research support from SK Life Science. The institution of Dr. Sperling has received research support from UCB Pharma . The institution of Dr. Sperling has received research support from Takeda. The institution of Dr. Sperling has received research support from Neurelis. The institution of Dr. Sperling has received research support from Engage Therapeutics . The institution of Dr. Sperling has received research support from Medtronic. The institution of Dr. Sperling has received research support from Cavion. The institution of Dr. Sperling has received research support from Xenon Pharma. The institution of Dr. Sperling has received research support from Cerevel. The institution of Dr. Sperling has received research support from National Institutes of Health . The institution of Dr. Sperling has received research support from DARPA. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Vice President with Epilepsy Consortium . |
John M. Stern, MD, FAAN | Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. |
Tammy Tsuchida, MD, PhD | The institution of Dr. Tsuchida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon Pharmaceuticals Inc. The institution of Dr. Tsuchida has received research support from Xenon Pharmaceuticals Inc. |
Katherine H. Noe, MD, PhD, FAAN | Dr. Noe has a non-compensated relationship as a committe member, Epilepsy MOC article review pilot with American Board of Psychiatry and Neurology that is relevant to AAN interests or activities. |
Sarah E. Schmitt, MD | Dr. Schmitt has nothing to disclose. |